Risk of Fracture with Thiazolidinediones: Disease or Drugs?

Marloes T. Bazelier, Peter Vestergaard, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Frank de Vries*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Pages (from-to)450-457
JournalCalcified Tissue International
Issue number6
Publication statusPublished - Jun 2012


  • Thiazolidinedione
  • Type 2 diabetes mellitus
  • Fracture risk
  • Osteoporosis

Cite this